BiotechTube
Aneuvo

Aneuvo

San Francisco, United States· Est.
aneuvo.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Aneuvo is a private, clinical-stage neurotechnology company pioneering non-invasive neuromodulation devices for spinal cord injury (SCI). Its flagship ExaStim system has received FDA Breakthrough Device designation and CE Mark approval, positioning it for clinical adoption in the US and Europe. The company is targeting a significant unmet need in neurorehabilitation with a portable, app-controlled therapy intended for use in both clinic and home settings.

Spinal Cord InjuryNeurological Disorders

Technology Platform

Transcutaneous Spinal Stimulation (TSS) delivered via a non-invasive, multi-electrode adhesive pad and controlled through a tablet application.

Funding History

2
Total raised:$15M
Series A$12M
Seed$3M

Opportunities

The large, underserved global spinal cord injury population represents a significant market with high unmet need.
The non-invasive, portable nature of ExaStim allows for therapy extension into the home, improving accessibility and creating a new category in neurorehabilitation.
Regulatory designations (FDA Breakthrough, CE Mark) provide a accelerated pathway and early market access.

Risk Factors

Clinical and regulatory risk remains, as full FDA approval requires successful trial completion.
Reimbursement from insurers is a major hurdle for novel therapeutic devices.
The company faces competition from both established invasive stimulator companies and other emerging neuromodulation technologies.

Competitive Landscape

Aneuvo competes in the broader neuromodulation market, which includes giants like Medtronic and Boston Scientific that sell invasive spinal cord stimulators for pain. Its direct competitors are other companies developing non-invasive spinal stimulation for motor recovery (e.g., SpineX, Onward Medical's external ARC system). Differentiation hinges on ExaStim's specific design, ease of use, portability, and clinical evidence.

More companies in Diagnostics & Precision Medicine →More companies in United States →